Page last updated: 2024-11-12

protosappanin b

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID13846689
SCHEMBL ID164076
MeSH IDM000612169

Synonyms (16)

Synonym
FT-0689654 ,
SCHEMBL164076
102036-29-3
protosappanin b
protosappanin-b
(-)-protosappanin b
(7s,12as)-7,8-dihydro-7-(hydroxymethyl)-6h-dibenz[b,d]oxocin-3,7,10,11-tetrol
mfcd20527297
6h-dibenz[b,d]oxocin-3,7,10,11-tetrol, 7,8-dihydro-7-(hydroxymethyl)-, (7s,12as)-
(10s)-10-(hydroxymethyl)-8-oxatricyclo[10.4.0.0^{2,7]hexadeca-1(16),2(7),3,5,12,14-hexaene-5,10,14,15-tetrol
(7s)-3,7,10,11-tetrahydroxy-7,8-dihydro-6h-dibenzo[b,d]oxocin-7-methanol
A896916
10-(hydroxymethyl)-8-oxatricyclo[10.4.0.02,7]hexadeca-1(16),2(7),3,5,12,14-hexaene-5,10,14,15-tetrol
DTXSID401317139
AS-79972
protosappaninb

Research Excerpts

Overview

Protosappanin B (PTB) is a unique homoisoflavone compound isolated from Sappan Lignum (the heartwood of Caesalpinia sappan L) It is a bioactive dibenzoxocin derivative.

ExcerptReferenceRelevance
"Protosappanin B (PSB) is a key active component of Lignum Sappan extract. "( Protosappanin B Exerts Anti-tumor Effects on Colon Cancer Cells via Inhibiting GOLPH3 Expression.
Chen, ZC; Hong, ZS; Pan, JP; Qiu, CZ; Shi, ZS; Wang, CX; Zheng, XC; Zhuang, HB,
)
3.02
"Protosappanin B (PTB) is a unique homoisoflavone compound isolated from Sappan Lignum (the heartwood of Caesalpinia sappan L)."( UPLC-ESI-Q-TOF/MS Based Metabolic Profiling of Protosappanin B in Rat Plasma, Bile, Feces, Urine and Intestinal Bacteria Samples.
Chen, WY; Guo, DA; Liang, GY; Liu, B; Wu, YS; Xu, FF; Zheng, ZL, 2021
)
1.6
"Protosappanin B (PTB) is a bioactive dibenzoxocin derivative isolated from Caesalpinia sappan L. "( Protosappanin B protects PC12 cells against oxygen-glucose deprivation-induced neuronal death by maintaining mitochondrial homeostasis via induction of ubiquitin-dependent p53 protein degradation.
Jiang, Y; Liao, LX; Song, FJ; Tu, PF; Yu, Q; Zeng, KW; Zhao, MB, 2015
)
3.3
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (66.67)24.3611
2020's2 (33.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 20.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index20.22 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.66 (4.65)
Search Engine Demand Index15.26 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (20.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]